Login / Signup
Alex S Befeler
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Phase Iii
Cardiac Surgery
Radiation Therapy
Uric Acid
Top Venues
Hepatology communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Michael P Curry
,
Hugo E Vargas
,
Alex S Befeler
,
Nikolaos T Pyrsopoulos
,
Vilas R Patwardhan
,
Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Hepatology communications
7 (1) (2023)
Michael P Curry
,
Hugo E Vargas
,
Alex S Befeler
,
Nikolaos T Pyrsopoulos
,
Vilas R Patwardhan
,
Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Hepatology communications
7 (1) (2023)
Michael P Curry
,
Hugo E Vargas
,
Alex S Befeler
,
Nikolaos T Pyrsopoulos
,
Vilas R Patwardhan
,
Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Hepatology communications
7 (1) (2023)
Michael P Curry
,
Hugo E Vargas
,
Alex S Befeler
,
Nikolaos T Pyrsopoulos
,
Vilas R Patwardhan
,
Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Hepatology communications
7 (1) (2023)
Michael P Curry
,
Hugo E Vargas
,
Alex S Befeler
,
Nikolaos T Pyrsopoulos
,
Vilas R Patwardhan
,
Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Hepatology communications
7 (1) (2023)